Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.

While old age is a known risk factor for developing active tuberculosis (TB), studies on TB in the population aged 60 years and older (considered elderly in this study) are few, especially in the developing world. Results of the TB prevalence survey in Uganda found high TB prevalence (570/100,000) i...

Full description

Bibliographic Details
Main Authors: Nicholas Sebuliba Kirirabwa, Derrick Kimuli, Seyoum DeJene, Carol Nanziri, Estella Birabwa, Daniel Ayen Okello, Pedro Guillermo Suarez, Samuel Kasozi, Raymond Byaruhanga, Deus Lukoye
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0208390
_version_ 1818588933692325888
author Nicholas Sebuliba Kirirabwa
Derrick Kimuli
Seyoum DeJene
Carol Nanziri
Estella Birabwa
Daniel Ayen Okello
Pedro Guillermo Suarez
Samuel Kasozi
Raymond Byaruhanga
Deus Lukoye
author_facet Nicholas Sebuliba Kirirabwa
Derrick Kimuli
Seyoum DeJene
Carol Nanziri
Estella Birabwa
Daniel Ayen Okello
Pedro Guillermo Suarez
Samuel Kasozi
Raymond Byaruhanga
Deus Lukoye
author_sort Nicholas Sebuliba Kirirabwa
collection DOAJ
description While old age is a known risk factor for developing active tuberculosis (TB), studies on TB in the population aged 60 years and older (considered elderly in this study) are few, especially in the developing world. Results of the TB prevalence survey in Uganda found high TB prevalence (570/100,000) in people over 65. We focused on treatment outcomes in the elderly to understand this epidemic better. We conducted a retrospective analysis of data from TB facility registers in Kampala City for the period 2014-2015. We analyzed the 2014-15 cohort with respect to age, sex, disease class, patients' human immunodeficiency virus (HIV) and directly observed therapy (DOT) status, type of facility, and treatment outcomes and compared findings in the elderly (≥60) and younger (<60) age groups. Of 15,429 records, 3.3% (514/15,429) were for elderly patients. The treatment success rate (TSR) among elderly TB patients (68.3%) was lower than that of the non-elderly (80.9%) and the overall TSR 80.5%, (12,417/15,429) in Kampala. Although the elderly were less likely to test positive for HIV than the young (AOR 0.39; 95% CI 0.33-0.48, p<0.001), they had a two-fold higher risk of unfavorable treatment outcomes (AOR 2.14; CI 1.84-2.72, p<0.001) and were more likely to die while on treatment (AOR 1.86; CI 1.27-2.73; p = 0.001). However, there was no statistically significantly difference between treatment outcomes among HIV-positive and HIV-negative elderly TB patients. Compared to the younger TB patients, elderly TB patients have markedly poorer treatment outcomes, although TB/HIV co-infection rates in this age group are lower.
first_indexed 2024-12-16T09:32:38Z
format Article
id doaj.art-a213aa3a070741c6bc082d101339576b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T09:32:38Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a213aa3a070741c6bc082d101339576b2022-12-21T22:36:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020839010.1371/journal.pone.0208390Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.Nicholas Sebuliba KirirabwaDerrick KimuliSeyoum DeJeneCarol NanziriEstella BirabwaDaniel Ayen OkelloPedro Guillermo SuarezSamuel KasoziRaymond ByaruhangaDeus LukoyeWhile old age is a known risk factor for developing active tuberculosis (TB), studies on TB in the population aged 60 years and older (considered elderly in this study) are few, especially in the developing world. Results of the TB prevalence survey in Uganda found high TB prevalence (570/100,000) in people over 65. We focused on treatment outcomes in the elderly to understand this epidemic better. We conducted a retrospective analysis of data from TB facility registers in Kampala City for the period 2014-2015. We analyzed the 2014-15 cohort with respect to age, sex, disease class, patients' human immunodeficiency virus (HIV) and directly observed therapy (DOT) status, type of facility, and treatment outcomes and compared findings in the elderly (≥60) and younger (<60) age groups. Of 15,429 records, 3.3% (514/15,429) were for elderly patients. The treatment success rate (TSR) among elderly TB patients (68.3%) was lower than that of the non-elderly (80.9%) and the overall TSR 80.5%, (12,417/15,429) in Kampala. Although the elderly were less likely to test positive for HIV than the young (AOR 0.39; 95% CI 0.33-0.48, p<0.001), they had a two-fold higher risk of unfavorable treatment outcomes (AOR 2.14; CI 1.84-2.72, p<0.001) and were more likely to die while on treatment (AOR 1.86; CI 1.27-2.73; p = 0.001). However, there was no statistically significantly difference between treatment outcomes among HIV-positive and HIV-negative elderly TB patients. Compared to the younger TB patients, elderly TB patients have markedly poorer treatment outcomes, although TB/HIV co-infection rates in this age group are lower.https://doi.org/10.1371/journal.pone.0208390
spellingShingle Nicholas Sebuliba Kirirabwa
Derrick Kimuli
Seyoum DeJene
Carol Nanziri
Estella Birabwa
Daniel Ayen Okello
Pedro Guillermo Suarez
Samuel Kasozi
Raymond Byaruhanga
Deus Lukoye
Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
PLoS ONE
title Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
title_full Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
title_fullStr Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
title_full_unstemmed Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
title_short Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
title_sort response to anti tuberculosis treatment by people over age 60 in kampala uganda
url https://doi.org/10.1371/journal.pone.0208390
work_keys_str_mv AT nicholassebulibakirirabwa responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT derrickkimuli responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT seyoumdejene responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT carolnanziri responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT estellabirabwa responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT danielayenokello responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT pedroguillermosuarez responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT samuelkasozi responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT raymondbyaruhanga responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda
AT deuslukoye responsetoantituberculosistreatmentbypeopleoverage60inkampalauganda